Spotlight: Elena Rosenberg-Carlson

Elena Rosenberg-Carlson, MPH, is a Public Administration Analyst with the Administrative Core at UCLA CHIPTS. She currently provides project management and analytical support for three CHIPTS projects dedicated to enhancing the implementation science knowledge necessary for Ending the HIV Epidemic. Elena recently returned to her home state of California after 11 wonderful (and chilly!) years in the Upper Midwest, and she is delighted to be part of the CHIPTS team.

After receiving her BA from Carleton College, Elena volunteered as an AmeriCorps VISTA for Allina Health in Minnesota. Her role was dedicated to supporting programs that aimed to improve community health and address health disparities. In her VISTA position, she also had the privilege of being part of the research staff for a community-based participatory research project in South Minneapolis, igniting her interest in health disparities research. She continued supporting this project as a research assistant during graduate school at the University of Michigan, where she additionally worked as a health promotion specialist for the University Health Service and facilitated a graduate-level intergroup dialogue course on race, health, and socio-economic status. Elena completed her master’s internship with the San Francisco Department of Public Health, where she was primarily dedicated to supporting HIV prevention planning for the jurisdiction.

After receiving her MPH, Elena worked for the Infectious Disease Division at the Minnesota Department of Health. She started as a health educator and communications specialist and later moved into a senior planner role. As a senior planner, she led outreach and communications efforts for Minnesota’s immunization information system, and she provided project management, strategic planning, evaluation, and quality improvement support for various activities within the Vaccine-Preventable Disease Section. She is excited to return to the world of HIV, put her passion for health disparities research to good use, and learn from her incredibly knowledgeable and committed colleagues as a new CHIPTS staff.

In her spare time, Elena enjoys singing, dancing, exploring new foods, hiking, and spending time with friends and family. While implementing social distancing during the COVID-19 pandemic, her nights are occupied by reading the news, video chatting, and watching Schitt’s Creek with her partner, Matt, and their dog-daughter, Stella.

Each month, we’re featuring a member of our CHIPTS family and their work! To see past spotlights, check them out on the spotlights page  and make sure to check back to see who we feature next!

CHIPTS at CROI 2020

March 11th, 2020- Some of our very own CHIPTS faculty and fellows were represented at the annual Conference on Retroviruses and Opportunistic Infection (CROI) 2020. This year’s conference was scheduled to take place in Boston, Massachusetts from March 8th-11th, 2020. However, due to rising COVID-19 public health concerns, the conference was made virtual.

Check out the work of our fellow CHIPTS members available for download here- CHIPTS Members and Affiliates Oral Abstracts and Poster Presentation List for CROI 2020

For more information about CROI 2020, visit their website or learn more in the Abstract E-Book.

NIH Public Access Compliance Workshop

March 24th, 2020- CHIPTS led a virtual training on how to manage publication compliance with the NIH Public Access Policy on Tuesday, March 24th, 2020 from 12pm-1pm.

This training emphasized steps for the following procedures:

  1. Submitting publications into the NIHMS system.
  2. Monitoring/tracking publication status using the NCBI My Bibliography base, alongside the NIHMS system.
  3. Linking publications to funding grants/awards, such as the CHIPTS grant.

The workshop’s agenda and presentation slides are available for download below. Additional support for publication compliance can also be found on our website under the main menu’s resources tab, on the NIH Public Access Policy page. 

NIH Public Access Policy Workshop (2020) - Flyer

 

NIH Public Access Policy Workshop (2020) - Slides

 

 

14th Annual CFAR Social and Behavioral Sciences Research Network (SBSRN) Conference Postponed

14th Annual CFAR Social and Behavioral Sciences Research Network (SBSRN) Conference

Scientific Meeting POSTPONED

Ending the HIV Epidemic: The Role of Social and Behavioral Sciences

Philadelphia, PA

The Executive Committee of the SBSRN met on March 10th and made the decision to postpone our annual meeting that was scheduled to take place in April. We anticipate holding the meeting later this year and will send out notice as soon as we are able to reschedule. We want to thank you all for your continued support of the SBSRN and look forward to seeing you in Philadelphia later this year. Stay close to home and stay healthy!

Notification of the new conference dates will be sent via e-mail to those who have already registered. If you have not yet registered and are interested in attending the conference, you may add your name and e-mail address to our mailing list here: https://redcap.link/SBSRN2020

[Download not found]

Digital PrEP

The preliminary report for this project is now available! Learn more and access the report on our website here.

February 10th, 2020- 70 participants attended the CHIPTS Digital PrEP event on Monday, February 10th, 2020 at the St. Anne’s Conference Center from 8:30AM-4:30PM. Both healthcare and tech-based PrEP providers were among those present alongside community partners as critical information was gathered on how mobile technology can be used to improve the delivery of Pre-Exposure Prophylaxis (PrEP) to Latino and Black MSM, Latina and Black cisgender and transgender women, and persons who inject drugs in Los Angeles County. The ultimate aim was to create a program capable of helping to facilitate adoption of PrEP among these groups.

Opening remarks were provided by Steve Shoptaw, Director of CHIPTS, followed by an overview of HIV incidence/prevalence in LA County by Sonali Kulkarni from Los Angeles Division of HIV/STD Programs (DHSP). Ronald Brooks, CHIPTS Core Scientist, highlighted essential goals for the day’s meeting, sharing prospects for mobile technology’s feasibility and acceptability in enhancing treatment persistence among racial/ethnic sexual and gender minority populations. Five technology-based PrEP providers then proceeded with individual presentations on the dynamic incorporation of PrEP within their tech services and its effectiveness in facilitating care. James Wantuck of PlushCare and Jessica Horwitz of Nurx served as representatives from telehealth agencies, while Jesse Thomas of e2PrEP and Eden Pudberry of Healthvana represented companies geared towards mobile application. Likewise, David Moore of Individualized Texting for Adherence Building (iTAB) gave insight into PrEP delivery strategies by SMS/text messaging services. A large group session was then led by Dilara Uskup, CHIPTS Postdoctoral Fellow, centering on core methods for gauging PrEP uptake and adherence among high priority LA communities. This segued into the day’s afternoon session featuring two rounds of concurrent breakout sessions on using technology-based PrEP services among the following priority populations: Latino Men Who Have Sex with Men, Black Men Who Have Sex with Men, Black and Latina Transgender Women, Latina Cisgender Women, Black Cisgender Women, and Persons Who Inject Drugs. CHIPTS members assisted with facilitating these breakout sessions including Omar Nieto, Ronald Brooks, Dilara Uskup, and Norweeta Milburn, CHIPTS Development Core Director. Additionally, Sung- Jae Lee, CHIPTS Methods Core Associate Director, mediated continuing conversations with present technology providers. Ronald Brooks and Dilara Uskup adjourned the day with crucial next steps.

The meeting agenda and presentation slides are available for download below. Visit the CHIPTS Facebook page for a mini gallery capturing some of the day’s highlights.

 

Technology-Based PrEP Delivery and Retention Services for Black and Latino MSM, Black and Latina Transgender and Cisgender Women, and Persons who Inject Drugs in LA County - Agenda

 

Technology-Based PrEP Delivery and Retention Services for Black and Latino MSM, Black and Latina Transgender and Cisgender Women, and Persons who Inject Drugs in LA County - Slides

Dr. Nina Harawa Reflects on National Black HIV/AIDS Awareness Day

In response to the LA Commission’s February colloquium in honor of National Black HIV/AIDS Awareness Day, Dr. Nina Harawa, CHIPTS Policy Impact Core Director, shared significant insight on the day’s panel discussion. Read more on her commentary below.

The PDF is also available for download here- LA HIV Commission Panel for NBHAAD - Reflection

“Reflections on February 13th LA HIV Commission Panel for NBHAAD” – Nina T. Harawa, MPH, PhD

Today’s panel in honor of NBHAAD raised a range of issues, concerns, and solutions.  Among other points, the stellar group of committed provider/advocates highlighted the changing healthcare landscape and workforce training needs.  The latter issue particularly drew my attention.  It is on days like these that I realize I have been in the HIV fight, in this corner of the epidemic, for a long time. Others have been in it even longer and will soon retire.

My first HIV Commission meeting was likely 24 years ago, and I remember well presenting to that very body while 8 months pregnant with my oldest daughter. She turns 16 soon. I have known three of the four panelists for at least a dozen years.  One panelist kept mentioning the grey beards in the room.  As a member of the “starting-to-grey sister lock set” and an educator, I argue that we must heed the call for efforts to ensure that a capable HIV workforce grows and remains steadfastly in place.  We need these individuals more than ever as we work to end the epidemic, while continuing to care for the million-plus people currently living with HIV in the US.

New people and young people bring energy and fresh perspectives.  Fortunately, there are some local efforts to tap and grow that energy.  They include CHIPTS’ HIV Next Generation Conference and pilot awards, Tru Evolution’s innovative plan to train a cadre of young adult MSM as HIV testing counselors so they can provide this service to their networks, Charles R. Drew University of Medicine and Science’s upcoming College Student HIV Testing Day on April 7th, and UCLA’s Sex Squad with its creative, sex-positive approach.

A crucial part of the panelists’ call was to increase the numbers of Black providers and researchers in the area of HIV. The vital role that Black/African American providers play in serving the needs of Black patients, including the ability to forge trusting partnerships with patients, cannot be overstated. Presenters and panelists vividly articulated this point in our conference on Medical Mistrust in Black/African American communities. Charles Drew University’s plan to open an independent 4-year medical school in fall 2023 that will add new cohorts of 60 students each year will also help meet that need by increasing the number of medical providers with the training and motivation to serve in communities of color.

Three other key points that were highlighted by panelists and echoed by the audience:

  • The fundamental role of social determinates of health in fueling the HIV epidemic in Black communities, including racism, homophobia/transphobia, poverty, and HIV stigma. As a scholar, I find Link and Phelan’s concept of “fundamental causes” to be crucial to thinking about these types of social determinates. Researchers, interventionists, and advocates should not miss opportunities to highlight the devastating impacts of these systems of power and privilege so that we address the root causes of poor health, rather than just the proximal determinates. (REF: Link/Phelan).
  • The importance of ongoing health-related education for patients and affected communities. This is a particular concern of mine. The HIV field has largely abandoned health education and risk reduction efforts under the assumption that they “do not work.” While I question some of the ways in which research findings have been interpreted to come to this conclusion, I recognize that intensive educational and skill-building interventions are challenging to bring to scale and sustain over time.  Nevertheless, they are necessary, even where not sufficient for addressing the challenge. Providing someone a biomedical intervention, whether as prevention or treatment, without educating them on what it is doing in their bodies or the other implications it has for their health is unethical and can have unforeseen negative consequences.  Furthermore, evidence is accumulating that many Black people who are at-risk for HIV may never adapt biomedical prevention.  Other options must remain available to them.
  • The often-profound impact of syndemic conditions on HIV in Black communities. These include mental illness and substance use disorders, but also social epidemics such as incarceration and homelessness. While Black people are often not overrepresented among those with many types of mental health conditions and substance use disorders, we often experience more frequent and more severe negative sequelae of these conditions because of our social and structural contexts. Comorbid conditions are a theme of our Center and these syndemics are ones that CHIPTS investigators know well and focus on in much of their work. We seek to intervene in effective ways with populations with co-occurring conditions and to examine the impact of policies that might ameliorate or worsen their impact.

I have long contended that successfully ending the HIV epidemic in Black America would require repairing many of the conditions, attitudes, and dynamics that harm the physical, social, economic, and emotional well-being of our communities.  This is a tall order.  PrEP and treatment as prevention may make it possible without such fundamental shifts.  Nevertheless, the panelist make clear that, even with these biomedical advances, we do need to move in the direction of these fundamental changes to have any chance of lasting success.

 

Colloquium: “National Black HIV/AIDS Awareness Day (NBHAAD)”

February 13th, 2020- This month’s commission meeting featured a panel discussion in honor of National Black HIV/AIDS Awareness Day, which commemorated this year on February 7th, 2020.  Moderators Danielle Campbell & Greg Wilson, Co-Chairs of the Black/African American Community (BAAC) Task Force led the conversation with panelists Dr. Derrick L. Butler from T.H.E. Health and Wellness Center, Dr. Condessa Curly from Los Angeles County Department of Public Health, Dr. William King from W King Health Care Group, and Dr. Rochelle Rawls from LAC+USC Medical Center’s Rand Schrader Clinic.

 

These medical providers gave insight into necessary efforts to effectively address barriers and social determinants of health continuing to disproportionately affect Black/African American communities. Perspectives were given from a combination of both their shared experiences and best practices, alongside concerns in resolving the epidemic and providing immersive opportunities to increase HIV education, testing, community involvement, and treatment. Significant solutions were identified by panelists and voiced by present community members, demonstrating the successive theme of unified support systems anchored in reducing stigma, increasing dissemination, and framing prevention of HIV/AIDS within black communities.

You can find the flyer available for download below as well as the full video of the panel (also available on Youtube).

We also encourage you to read this insightful commentary on the day’s panel discussion written by Dr. Nina Harawa, CHIPTS Policy Impact Core Director.

A National Black HIV/AIDS Awareness Day Panel Discussion - Flyer

 

 

CHIPTS hosts a monthly HIV Research and Community Colloquia Series in collaboration with the Los Angeles County Commission on HIV to highlight current issues and conversations surrounding HIV. Click here for past lectures and check out the events page for more information on future Colloquia presentations!

NATAP: PrEP in Pregnant/Postpartem Women Safety Review

New emerging evidence from a systematic review of the safety of PrEP for pregnant and postpartum women has been released in a new publication co-authored by CHIPTS members Dvora Davey, Thomas Coates, and Steven Shoptaw, Director of CHIPTS.

The abstract summary of the publication can be found below, alongside the full publication available for download here- [Download not found]

Introduction: HIV incidence is high during pregnancy and breastfeeding with HIV acquisition risk more than doubling during pregnancy and the postpartum period compared to when women are not pregnant. The World Health Organization recommends offering pre-exposure prophylaxis (PrEP) to pregnant and postpartum women at substantial risk of HIV infection. However, maternal PrEP national guidelines differ and most countries with high maternal HIV incidence are not offering PrEP. We conducted a systematic review of recent research on PrEP safety in pregnancy to inform national policy and rollout.

Methods: We used a standard Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) approach to conduct a systematic review by searching for completed, ongoing, or planned PrEP in pregnancy projects or studies from clinicaltrials.gov, PubMed and NIH RePORTER from 2014 to March 2019. We performed a systematic review of studies that
assess tenofovir disoproxil fumarate (TDF)-based oral PrEP safety in pregnant and breastfeeding HIV-uninfected women.

Results and discussion: We identified 14 completed (n = 5) and ongoing/planned (n = 9) studies that evaluate maternal and/or infant outcomes following PrEP exposure during pregnancy or breastfeeding. None of the completed studies found differences in pregnancy or perinatal outcomes associated with PrEP exposure. Nine ongoing studies, to be completed by 2022, will provide data on >6200 additional PrEP-exposed pregnancies and assess perinatal, infant growth and bone health outcomes, expanding by sixfold the data on PrEP safety in pregnancy. Research gaps include limited data on (1) accurately measured PrEP exposure within maternal and infant populations including drug levels needed for maternal protection; (2) uncommon perinatal outcomes (e.g. congenital anomalies); (3) infant outcomes such as bone growth beyond one year following PrEP exposure; (4) outcomes in HIV-uninfected women who use PrEP during pregnancy and/or lactation.

Conclusions: Expanding delivery of PrEP is an essential strategy to reduce HIV incidence in pregnancy and breastfeeding women. Early safety studies of PrEP among pregnant women without HIV infection are reassuring and ongoing/planned studies will contribute extensive new data to bolster the safety profile of PrEP use in pregnancy. However, addressing research gaps is essential to expanding PrEP delivery for women in the context of pregnancy.

Spotlight: William E. Cunningham

The CHIPTS community continues to mourn the passing of Dr. Billy Cunningham on January 3rd, 2020.  Dr. Cunningham has been an integral member of the CHIPTS scientific community for the duration of the center’s life-cycle.  Throughout Dr. Cunningham’s too brief life, he was a warrior for social justice. His energies focused with laser-like precision on finding ways to demolish barriers to health for those among us who have the least in our society. His research engaged ways to improve the health of members of race/ethnic and sexual/gender minorities who live with HIV and who become involved with the criminal justice system. These efforts remain groundbreaking and have set the agenda for interventions here locally in Los Angeles and even nationally.

Dr. Cunningham’s greatest joy was being a mentor – whether to postdocs, fellows and junior faculty, or to his friends and family, he taught us a most important lesson: “Don’t Quit.” Dr. Cunningham made sure that all of his mentees made our work relevant to changing lives and when problems arose to threaten our work, he would remind us: “Don’t Quit!” He invigorated in us all a deep commitment and energy toward our work, enlisting mentees and fellow faculty members to join him in the task of ensuring access to health care for all of us, but especially among those living with disparities.

At CHIPTS, we remember Dr. Cunningham, remain committed to continuing his body of work, and fight to reduce inequities for the betterment of the health of all.